RET and thyroid cancer: Interestingly, RET/PTC1TG mice heterozygous for the Patz1-knockout mutation do not significantly differ from RET/PTC1TG;Patz1+/+ control mice as far as thyroid tumor incidence is concerned, but their thyroid cancer phenotype is significantly more aggressive than that of controls.